Page last updated: 2024-08-26

terameprocol and Experimental Neoplasms

terameprocol has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CC; Chung, Y; Henry, RA; Huang, RC; Liang, YC; Lin, E; Mold, DE; Park, R1
Heller, JD; Huang, RC; Kast, WM; Kuo, J; Wu, TC1

Other Studies

2 other study(ies) available for terameprocol and Experimental Neoplasms

ArticleYear
Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jun-15, Volume: 11, Issue:12

    Topics: Administration, Oral; Animals; Area Under Curve; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Inhibitor of Apoptosis Proteins; Injections, Intravenous; K562 Cells; Masoprocol; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasms, Experimental; RNA, Messenger; Survivin; Tissue Distribution; Xenograft Model Antitumor Assays

2005
Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo.
    Cancer research, 2001, Jul-15, Volume: 61, Issue:14

    Topics: Animals; CDC2 Protein Kinase; Cell Division; Cell Line, Transformed; G2 Phase; Masoprocol; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; RNA, Messenger

2001